CFM
Comprehensive Financial Management’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.77M | Hold |
941,895
| – | – | 0.13% | 18 |
|
|
2025
Q1 | $4.98M | Hold |
941,895
| – | – | 0.16% | 15 |
|
|
2024
Q4 | $6.37M | Hold |
941,895
| – | – | 0.18% | 15 |
|
|
2024
Q3 | $6.21M | Hold |
941,895
| – | – | 0.17% | 17 |
|
|
2024
Q2 | $7.06M | Hold |
941,895
| – | – | 0.25% | 15 |
|
|
2024
Q1 | $9.39M | Hold |
941,895
| – | – | 0.3% | 12 |
|
|
2023
Q4 | $9.29M | Hold |
941,895
| – | – | 0.33% | 13 |
|
|
2023
Q3 | $7.21M | Sell |
941,895
-167,500
| -15% | -$1.28M | 0.26% | 14 |
|
|
2023
Q2 | $8.29M | Hold |
1,109,395
| – | – | 0.27% | 13 |
|
|
2023
Q1 | $7.4M | Hold |
1,109,395
| – | – | 0.22% | 13 |
|
|
2022
Q4 | $8.55M | Hold |
1,109,395
| – | – | 0.28% | 11 |
|
|
2022
Q3 | $11.8M | Hold |
1,109,395
| – | – | 0.31% | 12 |
|
|
2022
Q2 | $9.03M | Hold |
1,109,395
| – | – | 0.25% | 15 |
|
|
2022
Q1 | $7.94M | Hold |
1,109,395
| – | – | 0.14% | 16 |
|
|
2021
Q4 | $19M | Hold |
1,109,395
| – | – | 0.24% | 13 |
|
|
2021
Q3 | $25.5M | Hold |
1,109,395
| – | – | 0.24% | 12 |
|
|
2021
Q2 | $40.5M | Buy |
+1,109,395
| New | +$40.5M | 0.34% | 10 |
|